181 related articles for article (PubMed ID: 20726319)
1. Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma.
Allam MM; Abd El Moneim E; Hassouna MM; El Jaky A; Zaghlah H
Egypt J Immunol; 2009; 16(1):17-25. PubMed ID: 20726319
[TBL] [Abstract][Full Text] [Related]
2. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
Zahran AM; Hetta HF; Rayan A; Eldin AS; Hassan EA; Fakhry H; Soliman A; El-Badawy O
Cancer Immunol Immunother; 2020 Jul; 69(7):1253-1263. PubMed ID: 32170378
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST
Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion.
Wu X; Fan J; Wang X; Zhou J; Qiu S; Yu Y; Liu Y; Tang Z
Biochem Biophys Res Commun; 2007 Apr; 355(4):866-71. PubMed ID: 17336272
[TBL] [Abstract][Full Text] [Related]
6. Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection.
Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR
J Infect Dis; 2019 Apr; 219(9):1430-1438. PubMed ID: 30496498
[TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
8. [Chronic HCV-infection and expression of mRNA of CC-chemokines and their receptors].
Zhdanov KV; Gusev DA; Chirskiĭ VS; Sysoev KA; Iakubovskaia LA; Shakhmanov DM; Totolian AA
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):73-8. PubMed ID: 18822499
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
10. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
12. Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
Shiraki T; Takayama E; Magari H; Nakata T; Maekita T; Enomoto S; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Mizuno-Kamiya M; Yashiro K; Iguchi M; Tamai H; Kameyama Y; Kato J; Kondoh N; Ichinose M
Oncol Rep; 2011 Jul; 26(1):201-8. PubMed ID: 21491089
[TBL] [Abstract][Full Text] [Related]
13. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
[TBL] [Abstract][Full Text] [Related]
15. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.
Zhao N; Dang H; Ma L; Martin SP; Forgues M; Ylaya K; Hewitt SM; Wang XW
Hepatology; 2021 Mar; 73(3):1045-1060. PubMed ID: 32502310
[TBL] [Abstract][Full Text] [Related]
17. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
18. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
19. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
20. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.
Nansen A; Marker O; Bartholdy C; Thomsen AR
Eur J Immunol; 2000 Jul; 30(7):1797-806. PubMed ID: 10940868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
